Vanguard Group Inc Arvinas, Inc. Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Arvinas, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 8,362,200 shares of ARVN stock, worth $62.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,362,200

Previous 7,062,561 18.4%

Holding current value

$62.2 Million

Previous $135 Million 56.64%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$7.02 - $20.5 $9.12 Million - $26.6 Million	1,299,639 Added 18.4%	8,362,200 $58.7 Million
Q4 2024 Feb 11, 2025	BUY	$17.83 - $28.04 $1.01 Million - $1.59 Million	56,561 Added 0.81%	7,062,561 $135 Million
Q3 2024 Nov 13, 2024	BUY	$23.66 - $32.73 $7.91 Million - $10.9 Million	334,179 Added 5.01%	7,006,000 $173 Million
Q2 2024 Aug 13, 2024	BUY	$24.46 - $40.4 $9.11 Million - $15 Million	372,265 Added 5.91%	6,671,821 $178 Million
Q1 2024 May 10, 2024	BUY	$36.38 - $52.31 $52.7 Million - $75.8 Million	1,448,166 Added 29.85%	6,299,556 $260 Million
Q4 2023 Feb 14, 2024	BUY	$14.19 - $42.33 $3.45 Million - $10.3 Million	243,167 Added 5.28%	4,851,390 $200 Million
Q3 2023 Nov 14, 2023	BUY	$19.64 - $28.21 $1.78 Million - $2.55 Million	90,426 Added 2.0%	4,608,223 $90.5 Million
Q2 2023 Aug 14, 2023	BUY	$21.73 - $31.43 $518,760 - $750,328	23,873 Added 0.53%	4,517,797 $112 Million
Q1 2023 May 15, 2023	BUY	$26.15 - $37.26 $958,842 - $1.37 Million	36,667 Added 0.82%	4,493,924 $123 Million
Q4 2022 Feb 10, 2023	BUY	$32.47 - $57.24 $9 Million - $15.9 Million	277,192 Added 6.63%	4,457,257 $152 Million
Q3 2022 Nov 14, 2022	BUY	$41.87 - $57.99 $4.89 Million - $6.78 Million	116,877 Added 2.88%	4,180,065 $186 Million
Q2 2022 Aug 12, 2022	BUY	$36.01 - $74.24 $1.43 Million - $2.94 Million	39,607 Added 0.98%	4,063,188 $171 Million
Q1 2022 May 13, 2022	BUY	$60.27 - $81.57 $1.89 Million - $2.56 Million	31,372 Added 0.79%	4,023,581 $271 Million
Q4 2021 Feb 14, 2022	BUY	$65.85 - $96.21 $12.6 Million - $18.4 Million	191,277 Added 5.03%	3,992,209 $328 Million
Q3 2021 Nov 12, 2021	BUY	$73.2 - $107.87 $9.47 Million - $13.9 Million	129,320 Added 3.52%	3,800,932 $312 Million
Q2 2021 Aug 13, 2021	BUY	$60.45 - $84.26 $222 Million - $309 Million	3,671,612 New	3,671,612 $283 Million

Others Institutions Holding ARVN

# of Institutions

245

Shares Held

62.5M

Call Options Held

2.65M

Put Options Held

1.1M

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $396M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Arvinas, Inc. Transaction History